CClinicalTrials.gg
RecruitingNCT06472349Updated Apr 14, 2026

Structure and Function of the Upper Trapezius and Its Role in Chronic Shoulder Pain: an Investigation of Kinematics, Morphology, Muscle Quality and Activation Distribution

An observational study in Chronic Shoulder Pain, sponsored by National Yang Ming Chiao Tung University. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-14.

Sponsored by National Yang Ming Chiao Tung University · Observational

From the registry’s dates

  • Started Dec 2023; still recruiting 2 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Prior research has explored factors influencing muscle activation, including muscle thickness, fear avoidance beliefs (kinesiophobia), and somatosensory integration. In individuals with chronic shoulder pain, various characteristics impacting symptoms and treatment outcomes have been identified, such as psychosocial factors, fear avoidance, central sensitization, somatosensory impairments, and brain morphology changes. These shared characteristics affecting both muscle activation and chronic shoulder pain may potentially modulate upper trapezius muscle activation during functional movements in patients with chronic shoulder pain. Notably, there remains a gap in the literature concerning investigations into the upper trapezius muscle's morphology and quality, fear avoidance, central sensitization, somatosensory impairments, and their interplay with upper trapezius muscle activation in chronic shoulder pain patients.

To address these gaps, this study aims to: this study aims to: 1) compare different methods of measuring clavicular kinematics using an electromagnetic tracking system; 2) establish the reliability and validity of measuring muscle thickness and fat infiltration through ultrasound and magnetic resonance imaging; 3) compare shoulder kinematics, muscle activation, muscle morphology, and muscle fat infiltration in individuals with chronic shoulder pain with matched healthy controls; 4) explore the correlation between the factors that may influence upper trapezius muscle activation, including basic data of the subjects, muscle morphology, and muscle fat infiltration.

02

Conditions studied

  • Chronic Shoulder Pain
03

In context

Lead sponsor

National Yang Ming Chiao Tung University is the lead sponsor of 201 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Community Sample

Inclusion criteria

  • Chronic shoulder pain group

    • 18-50 years old18-50 years old
    • unilateral and non-traumatic shoulder pain
    • pain duration longer than 3 months
    • pain intensity more than VAS=2 during movement
    • presence 3 of 5 positive pain provocation tests: Hawkins-Kennedy test, Jobe test, or Neer's test Painful Arc, and Resistance Test against External Rotation.
  • Healthy control group

    • presenting no shoulder pain at rest or during daily activities
    • negative results of the pain provocation test: Hawkins-Kennedy test, Jobe test, Neer's test, Painful Arc, Resistance Test against External Rotation and Spurling's neck compression test.

Exclusion criteria

Exclusion Criteria:

- Chronic shoulder pain group

  • history of significant shoulder trauma, such as fracture or ultrasonography clinically suspected full thickness cuff tear
  • recent shoulder dislocation in the last 2 years
  • diagnosis of adhesive capsulitis characterized by a gradual and painful loss of both active and passive ROM in all shoulder planes, primarily external rotation
  • shoulder pain originating from the cervical spine by using Spurling's neck compression test
  • shoulder pain owing to the following disorders: arthritis (e.g., rheumatoid arthritis, osteoarthritis of shoulder complex), neurologic (e.g., stroke), neoplastic (e.g., breast cancer). and/or referred pain (e.g., visceral referred pain)
  • corticoid injections over the shoulder during 6 months prior to the study
  • history of shoulder and neck surgery
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Chronic shoulder pain group
  • Healthy control group
06

What researchers measure

Primary outcomes

  1. Shoulder kinematics

    The scapular kinematics will be assessed, including scapular internal/external rotation, upward/downward rotation, and posterior/anterior tilt angle. Clavicular kinematics will be evaluated by measuring clavicular protraction/retraction, elevation/depression, and posterior rotation angle.

    Time frame: During the procedure

  2. Muscle activation

    The average root mean square (RMS) value collected from surface EMG and outcomes collected by high-density EMG including average root mean square (RMS) value in whole/upper/lower regions, the RMS value distribution, and position of the barycentre of RMS distribution in different humeral elevation angles and different isometric shoulder and scapular tasks will be the outcome measures related to muscle activation.

    Time frame: During the procedure

Secondary outcomes

  1. Oscillation frequency

    The oscillation frequency (Hz) of the muscle obtained from the myotonometer will represent the muscle tone

    Time frame: During the procedure

  2. Dynamic stiffness

    The dynamic stiffness (N/m) of the muscle obtained from the myotonometer will represent the muscle tone

    Time frame: During the procedure

  3. Mechanical stress relaxation time (ms)

    The mechanical stress relaxation time (ms) of the muscle obtained from the myotonometer will represent the muscle tone

    Time frame: During the procedure

  4. Muscle thickness and cross-sectional area

    The upper, middle and lower trapezius muscle thickness and cross-sectional area obtained from MRI and the upper, middle and lower trapezius muscle thickness obtained from musculoskeletal sonography.

    Time frame: During the procedure

  5. Muscle thickness change at rest and in contraction

    The muscle thickness at rest, during arm raise at 90o abduction, during 2-kg abduction, during 4-kg abduction, and the change (%) between the latter three and at rest.

    Time frame: During the procedure

  6. Muscle fat quantification

    The upper, middle and lower trapezius muscle fat quantification indicate the muscle fat infiltration.

    Time frame: During the procedure

  7. Muscle / fat fraction

    The upper, middle and lower trapezius muscle / fat fraction indicate the muscle fat infiltration.

    Time frame: During the procedure

  8. Echo intensity

    The echo intensity of the upper, middle and lower trapezius muscle obtained from the musculoskeletal sonography.

    Time frame: During the procedure

  9. Pain intensity

    The score obtained from the VAS scale and NRPS scale during the most painful movement represent the pain intensity of the chronic shoulder pain group.

    Time frame: During the procedure

  10. Disability level

    The FLEX-SF score and DASH score will indicate the disability level of the subjects.

    Time frame: During the procedure

  11. Craniovertebral angle

    The cranial-vertebral angle will indicate the level of forward head posture.

    Time frame: During the procedure

07

Study locations

1 of 1 sites recruiting
  • National Yang Ming Chiao Tung University
    Taipei, 11221, Taiwan
    Recruiting
08

References and documents

Publications

  • Tang CK, Lu CF, Chiou SY, Shih YF. Characteristics of the upper trapezius muscle in patients with chronic shoulder impingement syndrome: a comparative study. Sci Rep. 2026 May 11;16(1):21532. doi: 10.1038/s41598-026-46757-7. PubMed 42115641 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06472349
Lead sponsor
National Yang Ming Chiao Tung University
Responsible party
Yi-Fen Shih (Professor, National Yang Ming Chiao Tung University) — Principal investigator
First posted
Jun 25, 2024
Start date
Dec 12, 2023
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion